These results are consistent with the general notion that resistin can act as an intrahepatic cytokine with proinflammatory activity in HSCs via a Ca2+/NF-κB-dependent pathway and involvement in the pathophysiology of liver fibrosis [18]. The gene discussed is NFKB1; the disease is Hepatic fibrosis.